Safety and Performance of a GLOBAL Mapping and Ablation Device for the Treatment of Atrial Fibrillation (GLOBAL-AF)
|2||Not yet recruiting||
Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
Atrial Fibrillation: Ablation or Surgical Treatment II: FAST II
† Study has passed its completion date and status has not been verified in more than two years.